Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL
Clinical trial NCT02268136 · TERMINATED
Trial details
- NCT number
- NCT02268136
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-04-01
- Primary completion
- 1999-12-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.